|
Real-time Estimate
Cboe BZX
11:06:06 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 2.295 USD | +3.15% |
|
-8.17% | -45.89% |
| Market Cap | 485M 434M 401M 363M 680M 46.13B 691M 4.83B 1.91B 24.13B 1.82B 1.78B 76.39B | P/E 2026 * |
-5.54x | P/E 2027 * | -4.42x |
|---|---|---|---|---|---|
| Enterprise Value | 485M 434M 401M 363M 680M 46.13B 691M 4.83B 1.91B 24.13B 1.82B 1.78B 76.39B | EV / Sales 2026 * |
19.4x | EV / Sales 2027 * | 19.1x |
| Free-Float |
94.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CTMX | Delayed | |
CBOE
| CTMX | Real-time | |
|
Tradegate
| 6C1 | Real-time | |
|
Deutsche Boerse AG
| 6C1 | Delayed | |
|
Börse Stuttgart
| 6C1 | Delayed | |
|
Berne S.E.
| 6C1 | End-of-day quote | |
|
Boerse Muenchen
| 6C1 | Real-time |
Last Transcript: CytomX Therapeutics, Inc.
| 1 day | +3.15% | ||
| 1 week | -8.17% | ||
| Current month | -15.26% | ||
| 1 month | -14.31% | ||
| 3 months | -29.08% | ||
| 6 months | -46.27% | ||
| Current year | -45.89% |
| 1 week | 2.16 |  | 2.61 |
| 1 month | 2.16 | | 2.82 |
| Current year | 2.16 | | 8.21 |
| 1 year | 2.16 | | 8.21 |
| 3 years | 0.4 | | 8.21 |
| 5 years | 0.4 | | 8.21 |
| 10 years | 0.4 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 59 | 2011-07-31 |
| Director of Finance/CFO | 42 | 2022-09-20 | |
Yu Waye Chu
CTO | Chief Tech/Sci/R&D Officer | 58 | 2023-07-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean McCarthy
CHM | Chairman | 59 | 2018-12-31 |
Matthew Young
BRD | Director/Board Member | 56 | 2015-08-31 |
James Meyers
BRD | Director/Board Member | 60 | 2018-12-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/3/26 | Free | General Counsel | 550,000 | 0.2524% | ||
| 7/24/26 | Free | Director | 118,000 | 0.0716% | ||
| 6/17/26 | Free | Director | 59,000 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.15% | -8.17% | -31.40% | +115.42% | 485M | |
| -3.10% | -3.43% | +36.29% | +67.69% | 65.28B | |
| +0.28% | +0.28% | +10.10% | +77.98% | 54.57B | |
| -0.13% | +1.63% | +9.78% | +101.91% | 53.59B | |
| +0.58% | +2.66% | +26.46% | +52.81% | 45.03B | |
| -2.17% | -5.37% | +15.36% | +113.48% | 42.17B | |
| +1.06% | -4.77% | +222.78% | +905.80% | 39.42B | |
| -2.26% | -4.14% | +15.38% | +45.53% | 32.71B | |
| -2.70% | -10.77% | +19.80% | -6.47% | 24.01B | |
| +1.38% | +15.72% | +61.02% | +50.02% | 26.5B | |
| Average | -0.38% | +1.37% | +38.56% | +152.42% | 38.38B | |
| Weighted average by Cap. | -0.82% | +1.78% | +43.37% | +155.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.03M 22.38M 20.71M 18.75M 35.09M 2.38B 35.67M 249M 98.57M 1.25B 93.95M 91.94M 3.94B | 25.34M 22.66M 20.96M 18.98M 35.53M 2.41B 36.11M 252M 99.79M 1.26B 95.11M 93.08M 3.99B |
| Net income | -78.11M -69.84M -64.62M -58.5M -109M -7.43B -111M -778M -308M -3.89B -293M -287M -12.31B | -111M -98.91M -91.51M -82.86M -155M -10.52B -158M -1.1B -436M -5.5B -415M -406M -17.43B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | US$2.310 | +3.82% | 977,746 |
| 26-10-26 | US$2.225 | -4.09% | 5,224,019 |
| 26-10-23 | US$2.320 | -4.92% | 4,365,988 |
| 26-10-22 | US$2.440 | +1.67% | 2,444,820 |
| 26-10-21 | US$2.400 | -4.38% | 3,111,059 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CTMX Stock
Select your edition
All financial news and data tailored to specific country editions
